-+ 0.00%
-+ 0.00%
-+ 0.00%

Septerna to Present Phase 1 Trial Data for SEP-631 in Mast Cell Diseases at 2026 AAAAI Meeting

Reuters·02/10/2026 13:00:18

Please log in to view news